Suchergebnisse - "Chen, Dongshu"

PubPharm (40)

1

SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms

enthalten in: Scientific reports | 2021

von Wang, Y. | Mohseni, M. | Grauel, A. | +45

2

Development of Anti-CD32b Antibodies with Enhanced Fc Function for the Treatment of B and Plasma Cell Malignancies

enthalten in: Molecular cancer therapeutics | 2020

von Lu, H. | Molony, R. | Chen, D. | +24

3

Toward the Validation of Maternal Embryonic Leucine Zipper Kinase : Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight

enthalten in: Journal of medicinal chemistry | 2016

von Touré, B. | Giraldes, J. | Smith, T. | +23

4

Toward the Validation of Maternal Embryonic Leucine Zipper Kinase: Discovery, Optimization of Highly Potent and Selective Inhibitors, and Preliminary Biology Insight

enthalten in: Journal of medicinal chemistry | 2016

von Touré, B. | Giraldes, J. | Smith, T. | +23

5

Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer

enthalten in: Cancer research | 2015

von Lantermann, A. | Chen, D. | McCutcheon, K. | +9

6

Inhibition of Casein Kinase 1 Alpha Prevents Acquired Drug Resistance to Erlotinib in EGFR-Mutant Non-Small Cell Lung Cancer

enthalten in: Cancer research | 2015

von Lantermann, A. | Chen, D. | McCutcheon, K. | +9

7

Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2014

von Hoffman, G. | Rahal, R. | Buxton, F. | +24

8

Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2014

von Hoffman, G. | Rahal, R. | Buxton, F. | +24

9

Functional epigenetics approach identifies BRM/SMARCA2 as a critical synthetic lethal target in BRG1-deficient cancers

Erschienen: 2014

von Hoffman, G. | Rahal, R. | Buxton, F. | +24

10

An antibody that locks HER3 in the inactive conformation inhibits tumor growth driven by HER2 or neuregulin

enthalten in: Cancer research | 2013

von Garner, A. | Bialucha, C. | Sprague, E. | +26